PCM
SYRS

Portolan Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Portolan Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$4.14M Sell
2020
Q3 		$3.99M Sell
2020
Q2 		$5.32M Sell
2020
Q1 		$3.04M Buy
2019
Q4 		$2.26M Buy